India Pharmaceutical Market Outlook 2030: Leading Companies & Share Insights

Amit Kumar
3 hours ago
4 min read

The India Pharmaceutical Market report by MarkNtel Advisors provides an in-depth analysis of market size, share, and growth prospects, offering valuable insights for stakeholders.

India Pharmaceutical Market Size & Insights

The India Pharmaceutical Market size was valued at around USD 53.29 billion in 2025 and is projected to reach USD 92.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.62% during the forecast period, i.e., 2025-30. The India Pharmaceutical Market is significantly growing due to several growth factors, including the growing burden of chronic diseases such as diabetes, cardiovascular diseases, & respiratory diseases, the rising healthcare requirements, the active government support, the rapid adoption of green and sustainable manufacturing of pharmaceutical products, etc. One of the most prominent growth factors is the rising global demand for Indian pharmaceuticals due to their affordable costs, approval by global regulators like the WHO and the USFDA. India has started to export pharmaceutical products such as drugs and vaccines to more than 200 countries, including the United States, Europe, and African countries.

What are the Key DROs in the India Pharmaceutical Market??

Rising Chronic Diseases – The pharmaceutical demand is rapidly growing due to the high severity of chronic diseases in the country, such as diabetes, cardiovascular diseases, tuberculosis, respiratory diseases, and many more. For instance, India has over 100 million individuals suffering from diabetes, while above 25% of the annual deaths in India are due to the rising cardiovascular diseases. Additionally, India has the highest tuberculosis patients globally, accounting for approximately 30% of the world’s total TB cases. For instance, in 2023, about 2.4 million new cases of TB were added in India.

Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/pharmaceutical-market-india.html

What are the Key Segments in the India Pharmaceutical Market?

The India Pharmaceutical is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:

By Product Type

Prescription Drugs
Over-the-counter Drugs
Biologics & Biosimilar
- Monoclonal Antibodies
- Hormones
- Vaccines

Out of these, the prescription drugs hold the largest market share of about 70%.

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Among these, the hospital pharmacies are dominating the market with an estimated market share of about 26%.

By End User

Hospitals and Clinics
Retail Consumers
Research & Academic Institutes.

How does geographical analysis highlight in the India Pharmaceutical market?

By Region

North
South
East
West
Central

Who are the Key Players in India Pharmaceutical Market?

Sun Pharmaceutical Industries Ltd.
Reddy’s Laboratories Ltd.
Cipla Ltd.
Lupin Ltd.
Aurobindo Pharma Ltd.
Zydus Lifesciences Ltd.
Torrent Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd.
Biocon Ltd.

Browse Full Reports – https://www.marknteladvisors.com/research-library/pharmaceutical-market-india.html

India Pharmaceutical Market News

2025: Sun Pharmaceutical Industries Ltd. launched a new drug, called Fexuclue® (Fexuprazan), in India to treat erosive esophagitis, a condition where stomach acid damages the esophagus.
2025: Dr. Reddy’s Laboratories Ltd. signed a strategic collaboration with Alvotech to co-develop, manufacture, and commercialize a biosimilar of Merck’s blockbuster immunotherapy drug Keytruda

Key pillars of the research methodology include:

Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.

"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.

Why This MarkNtel Advisors Research Report:

In-depth Market Analysis: Understand trends and dynamics shaping growth.
Segmented Insights: Target specific segments for focused strategies.
Geographical Performance: Assess market opportunities by geographic area.
Emerging Technologies: Discover advancements like AI integration.
Risk Identification: Pinpoint challenges to inform strategic planning.
Future Forecasts: Prepare for market changes with actionable projections.

Gain exclusive access to our comprehensive insights on the Future of India Pharmaceutical Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer – https://www.marknteladvisors.com/pricing/pharmaceutical-market-india.html

Our Trusted Experts Are Here to Help:

At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.